BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Policy

  FDA Cites Problems With CryoCor, Inc. Device

  June 25, 2007

   · 

  1 min read
• Business

  NiKem Research s.r.l. Enters Into Research Service Agreement with InterMune, Inc.

  June 25, 2007

   · 

  2 min read
• Policy

  TheraQuest Biosciences, LLC. Initiates GMP Manufacturing of Abuse Deterrent Sustained Release TQ-1015 Opioid: Novel Kappa Mechanism Reverses Morphine Tolerance

  June 25, 2007

   · 

  3 min read
• Drug Development

  Second Phase III Study Evaluating Gilead Sciences, Inc.'s (Jobs) Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint

  June 25, 2007

   · 

  9 min read
• BioMidwest

  Cook Medical To Present Symposium on Reducing Catheter Related Infections at 34th Annual APIC Conference

  June 25, 2007

   · 

  1 min read
• Drug Development

  Merck & Co., Inc.: Late Breaking Data Released at American Diabetes Association Showed that the Investigational Use of JANUVIA(TM) (sitagliptin) and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in P

  June 25, 2007

   · 

  1 min read
• Policy

  AmerisourceBergen Signs Agreement with DEA Leading to Reinstatement of Its Orlando Distribution Center’s Suspended License to Distribute Controlled Substances

  June 25, 2007

   · 

  1 min read
• Drug Development

  Roche Release: Earlier Initiation of Tamiflu(R) Treatment Improves Clinical Benefits for Children With Influenza

  June 25, 2007

   · 

  9 min read
• Genetown

  IBC Life Sciences’S 2nd International Stem Cells: Building the Bridge From R&D to Commercialization Conference to Address the Latest Approaches to Capitalize on Stem Cell Scientific Advances for Successful Commercialization

  June 25, 2007

   · 

  1 min read
• Genetown

  Javelin Pharmaceuticals Joins Russell 2000(R), 3000(R), Microcap(TM) and Global Indexes

  June 25, 2007

   · 

  1 min read